Literature DB >> 10510374

Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.

J A Whelan1, P R Dunbar, D A Price, M A Purbhoo, F Lechner, G S Ogg, G Griffiths, R E Phillips, V Cerundolo, A K Sewell.   

Abstract

Tetrameric peptide-MHC class I complexes ("tetramers") are proving invaluable as reagents for characterizing immune responses involving CTLs. However, because the TCR can exhibit a degree of promiscuity for binding peptide-MHC class I ligands, there is potential for cross-reactivity. Recent reports showing that the TCR/peptide-MHC interaction is dramatically dependent upon temperature led us to investigate the effects of incubation temperature on tetramer staining. We find that tetramers rapidly stain CTLs with high intensity at 37 degrees C. We examine the fine specificity of tetramer staining using a well-characterized set of natural epitope variants. Peptide variants that elicit little or no functional cellular response from CTLs can stain these cells at 4 degrees C but not at 37 degrees C when incorporated into tetramers. These results suggest that some studies reporting tetramer incubations at 4 degrees C could detect cross-reactive populations of CTLs with minimal avidity for the tetramer peptide, especially in the tetramer-low population. For identifying specific CTLs among polyclonal cell populations such as PBLs, incubation with tetramers at 37 degrees C improves the staining intensity of specific CTLs, resulting in improved separation of tetramer-high CD8+ cells. Confocal microscopy reveals that tetramers incubated at 37 degrees C can be rapidly internalized by specific CTLs into vesicles that overlap with the early endocytic compartment. This TCR-specific internalization suggests that coupling of tetramers or analogues with toxins, which are activated only after receptor internalization, may create immunotoxins capable of killing CTLs of single specificities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510374

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  The arrival of HLA class II tetramers.

Authors:  A J McMichael; A Kelleher
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.

Authors:  T L Whiteside
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

Review 3.  Development and use of multimeric major histocompatibility complex molecules.

Authors:  Tim F Greten; Jonathan P Schneck
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

4.  Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.

Authors:  V Rubio-Godoy; V Dutoit; D Rimoldi; D Lienard; F Lejeune; D Speiser; P Guillaume; J C Cerottini; P Romero; D Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

5.  Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.

Authors:  Annetie Oxenius; Andrew K Sewell; Sara J Dawson; Huldrych F Günthard; Marek Fischer; Geraldine M Gillespie; Sarah L Rowland-Jones; Catherine Fagard; Bernard Hirschel; Rodney E Phillips; David A Price
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

6.  Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.

Authors:  N H Gruener; F Lechner; M C Jung; H Diepolder; T Gerlach; G Lauer; B Walker; J Sullivan; R Phillips; G R Pape; P Klenerman
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

Authors:  SangKon Oh; Liyanage P Perera; Donald S Burke; Thomas A Waldmann; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

8.  Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin.

Authors:  Paul R Hess; Carie Barnes; Matthew D Woolard; Michael D L Johnson; John M Cullen; Edward J Collins; Jeffrey A Frelinger
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

9.  Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy.

Authors:  M Montes; N Rufer; V Appay; S Reynard; M J Pittet; D E Speiser; P Guillaume; J-C Cerottini; P Romero; S Leyvraz
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

10.  Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.

Authors:  Angel Varela-Rohena; Peter E Molloy; Steven M Dunn; Yi Li; Megan M Suhoski; Richard G Carroll; Anita Milicic; Tara Mahon; Deborah H Sutton; Bruno Laugel; Ruth Moysey; Brian J Cameron; Annelise Vuidepot; Marco A Purbhoo; David K Cole; Rodney E Phillips; Carl H June; Bent K Jakobsen; Andrew K Sewell; James L Riley
Journal:  Nat Med       Date:  2008-11-09       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.